ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.
Key opportunities in the protein labeling market include increasing demand for site-specific tags in proteomics and drug development, the rise of AI tools for protein structure prediction, and the ...
Abstract: As a category of intelligent fluid drive technology, the electro-conjugate fluid (ECF) drive technology has a broad application prospect in the field of soft robotics, with its advantages of ...
Read full article: ONLY ON 2: Woman speaks out after alleged unlawful, sexually charged traffic stop by former Prairie View officer Read full article: Court documents: Conroe sisters starved, tortured ...
Job seekers have faced a challenging year in 2025, with hiring systems driven by new artificial intelligence tools and complex application processes, according to a November report from LiveCareer. In ...
The Housing Authority of San Luis Obispo (HASLO) is preparing to open a new affordable housing community. Meadow Creek Apartments offers one, two, and three-bedroom apartments for working families, ...
Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications Orum Therapeutics ( ...
– BLA based on data from the global Phase 1/2 CADENZA trial NORTH CHICAGO, Ill., Sept. 30, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced submission of a new Biologics License Application ...
- BLA based on data from the global Phase 1/2 CADENZA trial PVEK is a CD123-targeting Antibody-Drug Conjugate (ADC) in clinical development for hematological malignancies (blood cancers), including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results